Population pharmacokinetics of tigecycline in critically ill patients
Objective: In critically ill patients, the change of pathophysiological status may affect the pharmacokinetic (PK) process of drugs. The purpose of this study was to develop a PK model for tigecycline in critically ill patients, identify the factors influencing the PK and optimiz dosing regimens.Met...
Main Authors: | Xiangru Luo, Shiyi Wang, Dong Li, Jun Wen, Na Sun, Guangjun Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1083464/full |
Similar Items
-
Population pharmacokinetics and individualized dosing of tigecycline for critically ill patients: a prospective study with intensive sampling
by: Wei Su, et al.
Published: (2024-01-01) -
Population Pharmacokinetics and Dosing Regimen of Lithium in Chinese Patients With Bipolar Disorder
by: Zi-bin Jin, et al.
Published: (2022-07-01) -
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
by: Gennaro De Pascale, et al.
Published: (2020-07-01) -
Population Pharmacokinetics of Meropenem in Critically Ill Korean Patients and Effects of Extracorporeal Membrane Oxygenation
by: Dong-Hwan Lee, et al.
Published: (2021-11-01) -
Population Pharmacokinetics of Tigecycline: A Systematic Review
by: Zhou CC, et al.
Published: (2022-06-01)